Global Whole Exome Sequencing Market 2023
According to the latest estimates, the global whole exome sequencing market is predicted to be growing at a CAGR of over 14.2% from 2023 to 2029. The top market companies…
RNA analysis research covers a wide range of topics-from large-scale analysis of the transcriptome-the complete set of RNA transcripts encoded by a genome-to studying the actions of individual small noncoding RNAs on specific genes. The market for RNA analysis worldwide is expected to reach USD 14,750 million by 2028, recording a CAGR of 9.1% over the forecast period as per the latest report by Gen Consulting Company.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global RNA analysis market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the RNA analysis industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the technology, and region. The global market for RNA analysis can be segmented by technology: microarrays, polymerase chain reaction (PCR), RNAi gene silencing, sequencing technologies. The polymerase chain reaction segment is estimated to account for the largest share of the global RNA analysis market. RNA analysis market is further segmented by region: Asia Pacific, Europe, North America, MEA (Middle East and Africa), Latin America. North America held the largest revenue share in 2021.
By technology:
– microarrays
– polymerase chain reaction (PCR)
– RNAi gene silencing
– sequencing technologies
By region:
– Asia Pacific
– Europe
– North America
– MEA (Middle East and Africa)
– Latin America
The market research report covers the analysis of key stake holders of the global RNA analysis market. Some of the leading players profiled in the report include Agilent Technologies Inc., Bio-Rad Laboratories, Inc., CD Genomics, Danaher Corp., Eurofins Scientific, Fluidigm Corp., Illumina, Inc., Merck KGaA, Promega Corp., Qiagen N.V., Roche Holding AG, Thermo Fisher Scientific Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
– To analyze and forecast the market size of the global RNA analysis market.
– To classify and forecast the global RNA analysis market based on technology, region.
– To identify drivers and challenges for the global RNA analysis market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global RNA analysis market.
– To identify and analyze the profile of leading players operating in the global RNA analysis market.
Why Choose This Report
– Gain a reliable outlook of the global RNA analysis market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
· Report description
· Objectives of the study
· Market segment
· Years considered for the report
· Currency
· Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
· Introduction
· Drivers
· Restraints
· Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY TECHNOLOGY
· Microarrays
· Polymerase chain reaction (PCR)
· RNAi gene silencing
· Sequencing technologies
PART 6. MARKET BREAKDOWN BY REGION
· Asia Pacific
· Europe
· North America
· MEA (Middle East and Africa)
· Latin America
PART 7. KEY COMPANIES
· Agilent Technologies Inc.
· Bio-Rad Laboratories, Inc.
· CD Genomics
· Danaher Corp.
· Eurofins Scientific
· Fluidigm Corp.
· Illumina, Inc.
· Merck KGaA
· Promega Corp.
· Qiagen N.V.
· Roche Holding AG
· Thermo Fisher Scientific Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
Agilent Technologies Inc.
Bio-Rad Laboratories, Inc.
CD Genomics
Danaher Corp.
Eurofins Scientific
Fluidigm Corp.
Illumina, Inc.
Merck KGaA
Promega Corp.
Qiagen N.V.
Roche Holding AG
Thermo Fisher Scientific Inc.
REPORT ATTRIBUTE | DETAILS |
---|---|
Base Year | 2021 |
Forecast Year | 2022-2028 |
According to the latest estimates, the global whole exome sequencing market is predicted to be growing at a CAGR of over 14.2% from 2023 to 2029. The top market companies…
The global continuous bioprocessing market, in terms of revenue, is expected to grow by 17.9 percent annually through 2029, according to the latest estimates. The top market companies profiles included…
The global virology testing market is projected to expand at a CAGR of ~1.2 percent across the forecast period of 2023 – 2029, according to the latest edition of the…
Please fill out our form and we will get back to you.